Hangzhou Coco Healthcare Products Co.Ltd. (301009) — Capital Reinvestment Ratio
Hangzhou Coco Healthcare Products Co.Ltd. (301009) has a Capital Reinvestment Ratio of 0.35x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥12.21 Million) in capital expenditures (CN¥4.26 Million). See 301009 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hangzhou Coco Healthcare Products Co.Ltd. Capital Reinvestment Ratio (2017–2024)
This chart tracks Hangzhou Coco Healthcare Products Co.Ltd.'s Capital Reinvestment Ratio across 7 annual periods. Check cash flow reinvestment rate of Hangzhou Coco Healthcare Products Co.Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)
Year-by-year Capital Reinvestment Ratio for Hangzhou Coco Healthcare Products Co.Ltd. from 2017 to 2024. For live market cap and broader valuation context, see Hangzhou Coco Healthcare Products Co.Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.44x | CN¥52.44 Million | CN¥75.35 Million | ▲ +395.7% |
| 2023 | 0.29x | CN¥227.70 Million | CN¥66.01 Million | ▼ -93.9% |
| 2021 | 4.76x | CN¥50.53 Million | CN¥240.45 Million | ▲ +753.6% |
| 2020 | 0.56x | CN¥395.86 Million | CN¥220.71 Million | ▼ -1.1% |
| 2019 | 0.56x | CN¥223.33 Million | CN¥125.86 Million | ▼ -28.3% |
| 2018 | 0.79x | CN¥114.26 Million | CN¥89.78 Million | ▲ +11.4% |
| 2017 | 0.71x | CN¥109.74 Million | CN¥77.41 Million | — |